Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/7535| Title: | Decizjonijiet storici : program 8 |
| Other Titles: | L-iskandlu tat-thalidomide |
| Authors: | Pirotta, Joseph Borg, Joseph |
| Keywords: | Thalidomide Medicine Health |
| Issue Date: | 2011 |
| Citation: | Pirotta, J. & Borg, J. (2011). Deċiżjonijiet storiċi [Radio series]. Malta: Campus FM |
| Abstract: | Thalidomide was first marketed in 1957 in West Germany under the trade-name Contergan. The German drug company Chemie Grünenthal developed and sold the drug. Primarily prescribed as a sedative or hypnotic, thalidomide also claimed to cure "anxiety, insomnia, gastritis, and tension". Afterwards, it was used against nausea and to alleviate morning sickness in pregnant women. Thalidomide became an over-the-counter drug in West Germany on October 1, 1957. Shortly after the drug was sold in West Germany, between 5,000 and 7,000 infants were born with phocomelia (malformation of the limbs). Only 40% of these children survived. |
| Description: | A programme about important historical decisions – both good and bad – which left a profound mark on international history. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/7535 |
| Appears in Collections: | Decizjonijiet storici |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| decizjonijiet 8.mp3 | radio program | 25.5 MB | Unknown | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.